Exercise induced Airway obstruction Laryngeal hyperreactivity
Conditions
Interventions
Children will receive placebo or 27,5 *g Fluticasone furoate in each nostril
for 4 weeks.
Sponsors
Medisch Spectrum Twente
Eligibility
Age
12 Years to 17 Years
Inclusion criteria
Inclusion criteria: children (12-17 years) with a history allergic rhinitis and/or allergic asthma able to perform lung-function FEV1>70% of predicted clinically stable for 3 weeks
Exclusion criteria
Exclusion criteria: Use of nasal/systemic steroids bronchodilators prior to test other cardiac or pulmonary disease signs of gastro-oesophagal reflux
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cold air exercise provocation test. Lungfunction will be determined with spirometric and oscillometric measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Asthma Controle Questionnaire by Juniper Borg scale of dyspneoa | — |
Countries
Netherlands
Outcome results
None listed